These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1583469)

  • 1. Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate.
    Di Paolantonio T; Mariani G; Ghirardini A; Gringeri A; Mannucci PM; Mastrullo L; De Biasi R; Giustarini G; Morfini M; Schiavoni M
    J Med Virol; 1992 Feb; 36(2):71-4. PubMed ID: 1583469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
    Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM
    Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
    Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU; Purcell RH
    Ann Intern Med; 1994 Jan; 120(1):1-7. PubMed ID: 7504424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virology of the hepatitis A epidemic in Italy.
    Purcell RH; Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU
    Vox Sang; 1994; 67 Suppl 4():2-7; discussion 24-6. PubMed ID: 7831866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the hepatitis A epidemics in hemophiliacs in Europe.
    Vermylen J; Peerlinck K
    Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
    Mannucci PM; Schimpf K; Brettler DB; Ciavarella N; Colombo M; Haschke F; Lechner K; Lusher J; Weissbach G
    Ann Intern Med; 1990 Jul; 113(1):27-32. PubMed ID: 2112352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
    Mannucci PM
    Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale preparation of a highly purified solvent-detergent treated factor VIII concentrate.
    Myers R; Wickerhauser M; Charamella L; Simon L; Nummy W; Brodniewicz-Proba T
    Vox Sang; 1991; 60(3):141-7. PubMed ID: 1907414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.
    Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B
    AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 12. Virus safety of solvent/detergent-treated antihaemophilic factor concentrate.
    Horowitz MS; Rooks C; Horowitz B; Hilgartner MW
    Lancet; 1988 Jul; 2(8604):186-9. PubMed ID: 2899662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.
    Duesberg PH
    Genetica; 1995; 95(1-3):51-70. PubMed ID: 7744263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].
    Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y
    Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D
    Genetica; 1995; 95(1-3):25-50. PubMed ID: 7538088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.
    Addiego JE; Gomperts E; Liu SL; Bailey P; Courter SG; Lee ML; Neslund GG; Kingdon HS; Griffith MJ
    Thromb Haemost; 1992 Jan; 67(1):19-27. PubMed ID: 1615478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
    Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, HBV and HCV seropositivity in hemophiliacs.
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transmission of the human immunodeficiency virus by a dry heat-treated Factor VIII concentrate?].
    Weisser J
    Klin Padiatr; 1988; 200(5):375-9. PubMed ID: 3141670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up of human anti-mouse antibody in multitransfused HIV negative haemophilics treated with a monoclonal purified plasma derived factor VIII concentrate.
    Smid WM; van der Meer J
    Thromb Haemost; 1995 Oct; 74(4):1203. PubMed ID: 8560440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.